Filing Details
- Accession Number:
- 0001127602-21-028634
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-11-08 20:59:52
- Reporting Period:
- 2021-11-05
- Accepted Time:
- 2021-11-08 20:59:52
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 816956 | Conmed Corp | CNMD | Electromedical & Electrotherapeutic Apparatus (3845) | 160977505 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1242753 | E Mark Tryniski | 1964 Penfold Way Baldwinsville NY 13027 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2021-11-05 | 4,892 | $51.90 | 13,188 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2021-11-05 | 4,792 | $156.51 | 8,396 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2021-11-05 | 100 | $157.11 | 8,296 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2021-11-05 | 3,399 | $69.03 | 11,695 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2021-11-05 | 2,899 | $156.44 | 8,796 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2021-11-05 | 500 | $157.06 | 8,296 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2021-11-05 | 2,886 | $79.94 | 11,182 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2021-11-05 | 2,386 | $156.44 | 8,796 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2021-11-05 | 500 | $156.95 | 8,296 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2021-11-05 | 1,843 | $73.94 | 10,139 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2021-11-05 | 1,743 | $156.48 | 8,396 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2021-11-05 | 100 | $157.05 | 8,296 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Options To Purchase Common Stock | Disposition | 2021-11-05 | 4,892 | $0.00 | 4,892 | $51.90 |
| Common Stock | Options To Purchase Common Stock | Disposition | 2021-11-05 | 3,399 | $0.00 | 3,399 | $69.03 |
| Common Stock | Options To Purchase Common Stock | Disposition | 2021-11-05 | 2,886 | $0.00 | 2,886 | $79.94 |
| Common Stock | Options To Purchase Common Stock | Disposition | 2021-11-05 | 1,843 | $0.00 | 1,843 | $73.94 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2018-06-01 | 2027-06-01 | No | 4 | M | Direct |
| 0 | 2019-06-01 | 2028-06-01 | No | 4 | M | Direct |
| 0 | 2020-06-01 | 2029-06-03 | No | 4 | M | Direct |
| 0 | 2021-06-01 | 2030-06-01 | No | 4 | M | Direct |
Footnotes
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $156.01 to $156.96. Full information regarding the number of shares sold at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $155.82 to $156.81. Full information regarding the number of shares sold at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $156.83 to $157.37. Full information regarding the number of shares sold at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $155.81 to $156.76. Full information regarding the number of shares sold at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $156.86 to $157.12. Full information regarding the number of shares sold at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $156.01 to $156.96. Full information regarding the number of shares sold at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder.
- The incentive stock options ("ISOs") were granted under the Company's 2016 Amended and Restated Non-Employee Director Equity Compensation Plan and generally vest 100% after a one year period.
- The stock options were granted under the Company's 2020 Amended and Restated Non-Employee Director Equity Compensation Plan and generally vest 100% after a one year period.
Billionaire Hedge Funds
